$TXN
Texas Instruments Inc

2021 Q1 Form 10-Q Financial Statement

#000009747621000013 Filed on April 28, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $4.289B $3.329B
YoY Change 28.84% -7.37%
Cost Of Revenue $1.492B $1.241B
YoY Change 20.23% -6.9%
Gross Profit $2.797B $2.088B
YoY Change 33.96% -7.65%
Gross Profit Margin 65.21% 62.72%
Selling, General & Admin $425.0M $417.0M
YoY Change 1.92% 0.72%
% of Gross Profit 15.19% 19.97%
Research & Development $386.0M $377.0M
YoY Change 2.39% -3.08%
% of Gross Profit 13.8% 18.06%
Depreciation & Amortization $179.0M $186.0M
YoY Change -3.76% 12.05%
% of Gross Profit 6.4% 8.91%
Operating Expenses $811.0M $794.0M
YoY Change 2.14% -1.12%
Operating Profit $1.939B $1.244B
YoY Change 55.87% -9.79%
Interest Expense -$46.00M -$45.00M
YoY Change 2.22% 18.42%
% of Operating Profit -2.37% -3.62%
Other Income/Expense, Net $46.00M $25.00M
YoY Change 84.0% -30.56%
Pretax Income $1.939B $1.224B
YoY Change 58.42% -11.11%
Income Tax $186.0M $50.00M
% Of Pretax Income 9.59% 4.08%
Net Earnings $1.753B $1.174B
YoY Change 49.32% -3.53%
Net Earnings / Revenue 40.87% 35.27%
Basic Earnings Per Share $1.89 $1.25
Diluted Earnings Per Share $1.87 $1.24
COMMON SHARES
Basic Shares Outstanding 922.0M shares 931.0M shares
Diluted Shares Outstanding 935.0M shares 943.0M shares

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.686B $4.742B
YoY Change 41.0% 16.05%
Cash & Equivalents $2.442B $2.518B
Short-Term Investments $4.244B $2.224B
Other Short-Term Assets $245.0M $249.0M
YoY Change -1.61% -15.31%
Inventory $1.890B $2.003B
Prepaid Expenses
Receivables $1.584B $1.316B
Other Receivables $0.00 $0.00
Total Short-Term Assets $10.41B $8.310B
YoY Change 25.21% 4.52%
LONG-TERM ASSETS
Property, Plant & Equipment $3.431B $3.233B
YoY Change 6.12% -11.76%
Goodwill $4.362B $4.360B
YoY Change 0.05%
Intangibles
YoY Change
Long-Term Investments $52.00M $34.00M
YoY Change 52.94% -88.96%
Other Assets $657.0M $493.0M
YoY Change 33.27% -3.52%
Total Long-Term Assets $9.234B $8.973B
YoY Change 2.91% -5.47%
TOTAL ASSETS
Total Short-Term Assets $10.41B $8.310B
Total Long-Term Assets $9.234B $8.973B
Total Assets $19.64B $17.28B
YoY Change 13.63% -0.92%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $567.0M $363.0M
YoY Change 56.2% -23.9%
Accrued Expenses $855.0M $905.0M
YoY Change -5.52% 10.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $1.051B
YoY Change -100.0% 40.13%
Total Short-Term Liabilities $1.700B $2.381B
YoY Change -28.6% 10.28%
LONG-TERM LIABILITIES
Long-Term Debt $6.250B $5.499B
YoY Change 13.66% 8.74%
Other Long-Term Liabilities $1.305B $1.510B
YoY Change -13.58% -2.27%
Total Long-Term Liabilities $7.555B $7.009B
YoY Change 7.79% 353.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.700B $2.381B
Total Long-Term Liabilities $7.555B $7.009B
Total Liabilities $9.473B $9.549B
YoY Change -0.8% 7.0%
SHAREHOLDERS EQUITY
Retained Earnings $42.86B $40.23B
YoY Change 6.55%
Common Stock $4.132B $3.837B
YoY Change 7.69%
Preferred Stock
YoY Change
Treasury Stock (at cost) $36.48B $36.00B
YoY Change 1.32%
Treasury Stock Shares 817.6M shares 819.3M shares
Shareholders Equity $10.17B $7.734B
YoY Change
Total Liabilities & Shareholders Equity $19.64B $17.28B
YoY Change 13.63% -0.92%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $1.753B $1.174B
YoY Change 49.32% -3.53%
Depreciation, Depletion And Amortization $179.0M $186.0M
YoY Change -3.76% 12.05%
Cash From Operating Activities $1.850B $851.0M
YoY Change 117.39% -23.13%
INVESTING ACTIVITIES
Capital Expenditures $308.0M $161.0M
YoY Change 91.3% -35.86%
Acquisitions
YoY Change
Other Investing Activities $20.00M $5.000M
YoY Change 300.0% -61.54%
Cash From Investing Activities -$1.109B $826.0M
YoY Change -234.26% -29.58%
FINANCING ACTIVITIES
Cash Dividend Paid $940.0M $841.0M
YoY Change 11.77% 16.16%
Common Stock Issuance & Retirement, Net $100.0M $1.641B
YoY Change -93.91% 42.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$1.406B -$1.596B
YoY Change -11.9% 59.92%
NET CHANGE
Cash From Operating Activities $1.850B $851.0M
Cash From Investing Activities -$1.109B $826.0M
Cash From Financing Activities -$1.406B -$1.596B
Net Change In Cash -$665.0M $81.00M
YoY Change -920.99% -93.68%
FREE CASH FLOW
Cash From Operating Activities $1.850B $851.0M
Capital Expenditures $308.0M $161.0M
Free Cash Flow $1.542B $690.0M
YoY Change 123.48% -19.39%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000097476
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-03761
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
TEXAS INSTRUMENTS INCORPORATED
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-0289970
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
12500 TI Boulevard
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Dallas
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75243
CY2021Q1 dei City Area Code
CityAreaCode
214
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
479-3773
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $1.00
CY2021Q1 dei Trading Symbol
TradingSymbol
TXN
CY2021Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
923523523 shares
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4289000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3329000000 USD
CY2021Q1 us-gaap Cost Of Revenue
CostOfRevenue
1492000000 USD
CY2020Q1 us-gaap Cost Of Revenue
CostOfRevenue
1241000000 USD
CY2021Q1 us-gaap Gross Profit
GrossProfit
2797000000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
2088000000 USD
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
386000000 USD
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
377000000 USD
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
425000000 USD
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
417000000 USD
CY2021Q1 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
47000000 USD
CY2020Q1 us-gaap Amortization Of Acquisition Costs
AmortizationOfAcquisitionCosts
50000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1939000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1244000000 USD
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
46000000 USD
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
25000000 USD
CY2021Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
46000000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
45000000 USD
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1939000000 USD
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1224000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
186000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1753000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.87
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
922000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
931000000 shares
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
935000000 shares
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
943000000 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1753000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
8000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
6000000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1745000000 USD
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1168000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1753000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-2000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodTax
-3000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
5000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Net Unamortized Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax
9000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-3000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossTax
-2000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-8000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-8000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Before Reclassification Adjustments Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesBeforeReclassificationAdjustmentsTax
0 USD
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 USD
CY2020Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2000000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
13000000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
19000000 USD
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1766000000 USD
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1193000000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2442000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3107000000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
4244000000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
3461000000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9000000 USD
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
11000000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1584000000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1414000000 USD
CY2021Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
183000000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
180000000 USD
CY2021Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
980000000 USD
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
964000000 USD
CY2021Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
727000000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
811000000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
1890000000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
1955000000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
245000000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
302000000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
10405000000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
10239000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5967000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5781000000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2536000000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2512000000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3431000000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3269000000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
4362000000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
4362000000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
105000000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
152000000 USD
CY2021Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
331000000 USD
CY2020Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
343000000 USD
CY2021Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
113000000 USD
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
122000000 USD
CY2021Q1 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
235000000 USD
CY2020Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
246000000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
657000000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
618000000 USD
CY2021Q1 us-gaap Assets
Assets
19639000000 USD
CY2020Q4 us-gaap Assets
Assets
19351000000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
550000000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
567000000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
415000000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
388000000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
767000000 USD
CY2021Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
278000000 USD
CY2020Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
134000000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
467000000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
524000000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
1700000000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2390000000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6250000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6248000000 USD
CY2021Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
130000000 USD
CY2020Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
131000000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
88000000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
90000000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1305000000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1305000000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
9473000000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
10164000000 USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
25
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
2400000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1740815939 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1740815939 shares
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1741000000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1741000000 USD
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2391000000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2333000000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42860000000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
42051000000 USD
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
817573099 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
821461787 shares
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
36479000000 USD
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
36578000000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-347000000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-360000000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
10166000000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9187000000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19639000000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
19351000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1753000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2021Q1 us-gaap Depreciation
Depreciation
179000000 USD
CY2020Q1 us-gaap Depreciation
Depreciation
186000000 USD
CY2021Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
47000000 USD
CY2020Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
50000000 USD
CY2021Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
15000000 USD
CY2020Q1 us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
14000000 USD
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
61000000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
63000000 USD
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
1000000 USD
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 USD
CY2021Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
8000000 USD
CY2020Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-34000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
170000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
242000000 USD
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-65000000 USD
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2000000 USD
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-73000000 USD
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
88000000 USD
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
69000000 USD
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
0 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-379000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-353000000 USD
CY2021Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
131000000 USD
CY2020Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
147000000 USD
CY2021Q1 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
28000000 USD
CY2020Q1 us-gaap Increase Decrease In Pension And Postretirement Obligations
IncreaseDecreaseInPensionAndPostretirementObligations
27000000 USD
CY2021Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
29000000 USD
CY2020Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
91000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1850000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
851000000 USD
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
308000000 USD
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
161000000 USD
CY2021Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
1000000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2021Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
2782000000 USD
CY2020Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
646000000 USD
CY2021Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
2000000000 USD
CY2020Q1 us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
1638000000 USD
CY2021Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
20000000 USD
CY2020Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
5000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1109000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
826000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 USD
CY2020Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
749000000 USD
CY2021Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
550000000 USD
CY2020Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2021Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
940000000 USD
CY2020Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
841000000 USD
CY2021Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100000000 USD
CY2020Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1641000000 USD
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
196000000 USD
CY2020Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
146000000 USD
CY2021Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000000 USD
CY2020Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-9000000 USD
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1406000000 USD
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1596000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-665000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
81000000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3107000000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2437000000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2442000000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2518000000 USD
CY2021Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 reportable_segment
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4289000000 USD
CY2021Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4289000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3329000000 USD
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1939000000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
1244000000 USD
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3329000000 USD
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1753000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
8000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Basic
UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic
6000000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1745000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
922000000 shares
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.89
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1168000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
931000000 shares
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.25
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
13000000 shares
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
12000000 shares
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
1753000000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
1174000000 USD
CY2021Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
8000000 USD
CY2020Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
6000000 USD
CY2021Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1745000000 USD
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
935000000 shares
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.87
CY2020Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
1168000000 USD
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
943000000 shares
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.24
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3000000 shares
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9000000 shares
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
6250000000 USD
CY2021Q1 txn Estimated Annual Effective Income Tax Rate Continuing Operations
EstimatedAnnualEffectiveIncomeTaxRateContinuingOperations
0.14
CY2021Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2021Q1 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
275000000 USD
CY2020Q1 txn Income Tax Reconciliation Income Tax Expense Benefit At Estimated Annual Effective Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtEstimatedAnnualEffectiveIncomeTaxRate
166000000 USD
CY2021Q1 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
89000000 USD
CY2020Q1 txn Income Tax Reconciliation Discrete Tax Items
IncomeTaxReconciliationDiscreteTaxItems
116000000 USD
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
186000000 USD
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
50000000 USD
CY2021Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.10
CY2020Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.04
CY2021Q1 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
2442000000 USD
CY2021Q1 us-gaap Short Term Investments
ShortTermInvestments
4244000000 USD
CY2021Q1 us-gaap Long Term Investments
LongTermInvestments
70000000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
3107000000 USD
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
3461000000 USD
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
49000000 USD
CY2021Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease
0 USD
CY2020Q1 us-gaap Debt Securities Available For Sale Allowance For Credit Loss Period Increase Decrease
DebtSecuritiesAvailableForSaleAllowanceForCreditLossPeriodIncreaseDecrease
0 USD
CY2021Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
2000000000.00 USD
CY2020Q1 us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
1390000000 USD
CY2021Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
50000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Remainder Of Fiscal Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesRemainderOfFiscalYearFairValue
4647000000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
50000000 USD
CY2020Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
253000000 USD
CY2021Q1 us-gaap Commercial Paper
CommercialPaper
0 USD
CY2021Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6300000000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
6850000000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
52000000 USD
CY2020Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
45000000 USD
CY2021Q1 us-gaap Long Term Debt
LongTermDebt
6250000000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
6798000000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
550000000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6250000000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6248000000 USD
CY2021Q1 us-gaap Interest And Debt Expense
InterestAndDebtExpense
46000000 USD
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.02
CY2021Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.02
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.90
CY2020Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.90
CY2021Q1 us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
Contingencies<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification guarantees</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranty costs/product liabilities</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various legal and administrative proceedings. Although it is not possible to predict the outcome of these matters, we believe that the results of these proceedings will not have a material adverse effect on our financial condition, results of operations or liquidity.</span></div>
CY2021Q1 us-gaap Guarantees Indemnifications And Warranties Policies
GuaranteesIndemnificationsAndWarrantiesPolicies
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnification guarantees</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely sell products with an intellectual property indemnification included in the terms of sale. Historically, we have had only minimal, infrequent losses associated with these indemnities. Consequently, we cannot reasonably estimate any future liabilities that may result.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Warranty costs/product liabilities</span></div><div style="margin-bottom:12pt;margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We accrue for known product-related claims if a loss is probable and can be reasonably estimated. During the periods presented, there have been no material accruals or payments regarding product warranty or product liability. Historically, we have experienced a low rate of payments on product claims. Although we cannot predict the likelihood or amount of any future claims, we do not believe they will have a material adverse effect on our financial condition, results of operations or liquidity. Our stated warranties for semiconductor products obligate us to repair, replace or credit the purchase price of a covered product back to the buyer. Product claim consideration may exceed the price of our products.</span></div>
CY2021Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
4465552 shares

Files In Submission

Name View Source Status
0000097476-21-000013-index-headers.html Edgar Link pending
0000097476-21-000013-index.html Edgar Link pending
0000097476-21-000013.txt Edgar Link pending
0000097476-21-000013-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12021txnex31a.htm Edgar Link pending
q12021txnex31b.htm Edgar Link pending
q12021txnex32a.htm Edgar Link pending
q12021txnex32b.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
txn-20210331.htm Edgar Link pending
txn-20210331.xsd Edgar Link pending
txn-20210331_cal.xml Edgar Link unprocessable
txn-20210331_def.xml Edgar Link unprocessable
txn-20210331_htm.xml Edgar Link completed
txn-20210331_lab.xml Edgar Link unprocessable
txn-20210331_pre.xml Edgar Link unprocessable